Literature DB >> 28109463

Head and neck sarcomas: A single institute series.

Leandros-Vassilios Vassiliou1, Bagrat Lalabekyan2, Amrita Jay2, Colin Liew2, Jeremy Whelan2, Laurence Newman3, Nicholas Kalavrezos2.   

Abstract

BACKGROUND: Sarcomas are tumours of mesenchymal origin, accounting for 1% of all malignancies.
METHODS: This is a retrospective analysis of 107 head and neck sarcoma cases, treated over a period of thirteen years.
RESULTS: Fifty-four patients had with craniofacial bone sarcomas (BSs) (male: 33; female: 21) with high grade osteosarcoma being the most predominant type. The soft tissue sarcomas (STS) (53 patients; male: 28, female: 25) were histologically diverse with rhabdomyosarcomas and myxofibrosarcomas being the predominant types. The majority of BSs were managed with neoadjuvant chemotherapy followed by surgery, whereas in STSs treatment included predominantly surgery followed by radiotherapy. Overall survival estimates were 79% at 2years and 64% at 5years (mean follow-up period was 48months).
CONCLUSIONS: The mesenchymal origin of sarcomas, the pattern of disease spread and the different extent of cancellous bone infiltration in contrast to epithelial tumours, dictate distinct principles for surgical clearance.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Head and neck; Mandible; Maxilla; Maxillofacial; Oncology; Oral; Osteosarcoma; Sarcoma

Mesh:

Year:  2016        PMID: 28109463     DOI: 10.1016/j.oraloncology.2016.12.005

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  6 in total

1.  The occurrence and pattern of head and neck sarcomas: a comprehensive cancer center experience.

Authors:  Deborah Gondim Lambert Moreira; Leorik Pereira da Silva; Everton Freitas de Morais; Salomão Israel Monteiro Lourenço Queiroz; Edilmar de Moura Santos; Lélia Batista de Souza; Roseana de Almeida Freitas
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-04       Impact factor: 2.503

2.  Prevalence of Head and Neck Sarcoma in a Major Cancer Center in Iran- A 10-Year Study.

Authors:  Saede Atarbashi-Moghadam; Amir Nader Emami Razavi; Saman Salehi Zalani
Journal:  Iran J Otorhinolaryngol       Date:  2019-03

3.  Macrophages-derived exosomal lncRNA LIFR-AS1 promotes osteosarcoma cell progression via miR-29a/NFIA axis.

Authors:  Hongliang Zhang; Yiyang Yu; Jun Wang; Yu Han; Tingting Ren; Yi Huang; Chenglong Chen; Qingshan Huang; Wei Wang; Jianfang Niu; Jingbing Lou; Wei Guo
Journal:  Cancer Cell Int       Date:  2021-04-01       Impact factor: 5.722

Review 4.  Long Noncoding RNA LIFR-AS1: A New Player in Human Cancers.

Authors:  Zhiqun Bai; Xuemei Wang; Zhen Zhang
Journal:  Biomed Res Int       Date:  2022-01-13       Impact factor: 3.411

Review 5.  Ossifying Fibromyxoid tumor of soft parts in head and neck: case report and literature review.

Authors:  Ignacio A Velasco; Ran Zhang; Tiejun Li; Diancan Wang
Journal:  Diagn Pathol       Date:  2018-03-27       Impact factor: 2.644

6.  Curcumin Derivative C086 Combined with Cisplatin Inhibits Proliferation of Osteosarcoma Cells.

Authors:  Xi Jiang; Yulin Huang
Journal:  Med Sci Monit       Date:  2020-07-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.